Identification and validation of a novel prognostic signature based on mitochondria and oxidative stress related genes for glioblastoma

[1]  Y. Pang,et al.  A BAK subdomain that binds mitochondrial lipids selectively and releases cytochrome C , 2022, Cell Death & Differentiation.

[2]  Zhuting Tong,et al.  Development and validation of an autophagy-related long non-coding RNA prognostic signature for cervical squamous cell carcinoma and endocervical adenocarcinoma , 2022, Frontiers in Oncology.

[3]  Jun Zhang,et al.  Identification of EMT-associated LncRNA Signature for Predicting the Prognosis of Patients with Endometrial Cancer. , 2022, Combinatorial chemistry & high throughput screening.

[4]  Teng-yue Zeng,et al.  A novel 17 apoptosis-related genes signature could predict overall survival for bladder cancer and its associations with immune infiltration , 2022, Heliyon.

[5]  Yue Zhou,et al.  Pan-Cancer Analysis Reveals SH3TC2 as an Oncogene for Colorectal Cancer and Promotes Tumorigenesis via the MAPK Pathway , 2022, Cancers.

[6]  A. Acharya,et al.  Identification of Key Pyroptosis-Related Genes and Distinct Pyroptosis-Related Clusters in Periodontitis , 2022, Frontiers in Immunology.

[7]  Yuhong Wang,et al.  Breast Cancer Prognosis Prediction and Immune Pathway Molecular Analysis Based on Mitochondria-Related Genes , 2022, Genetics research.

[8]  Huachun Yin,et al.  Drp1-Mediated Mitochondrial Metabolic Dysfunction Inhibits the Tumor Growth of Pituitary Adenomas , 2022, Oxidative medicine and cellular longevity.

[9]  Jihong Liu,et al.  A Mitochondrial Dysfunction and Oxidative Stress Pathway-Based Prognostic Signature for Clear Cell Renal Cell Carcinoma , 2021, Oxidative medicine and cellular longevity.

[10]  Wen Ai,et al.  Schisandrin B Antagonizes Cardiotoxicity Induced by Pirarubicin by Inhibiting Mitochondrial Permeability Transition Pore (mPTP) Opening and Decreasing Cardiomyocyte Apoptosis , 2021, Frontiers in Pharmacology.

[11]  Yang Xu,et al.  Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomas , 2021, Cancer medicine.

[12]  Elias S. J. Arnér,et al.  Thioredoxin Reductase Inhibition for Cancer Therapy. , 2021, Annual review of pharmacology and toxicology.

[13]  S. Murray,et al.  Glioblastoma: clinical presentation, diagnosis, and management , 2021, BMJ.

[14]  Zhiwei Cao,et al.  Rank-in: enabling integrative analysis across microarray and RNA-seq for cancer , 2021, Nucleic acids research.

[15]  Bo Wang,et al.  Expressions and significances of CTSL, the target of COVID‐19 on GBM , 2021, Journal of Cancer Research and Clinical Oncology.

[16]  Kaoxiang Sun,et al.  Synthesis and Characterization of a Series of Temozolomide Esters and Its Anti-glioma Study. , 2021, Journal of pharmaceutical sciences.

[17]  S. Pauklin,et al.  ROS and TGFβ: from pancreatic tumour growth to metastasis , 2021, Journal of experimental & clinical cancer research : CR.

[18]  Yu-Wen Lin,et al.  Cinnamophilin enhances temozolomide-induced cytotoxicity against malignant glioma: the roles of ROS and cell cycle arrest , 2021, Translational cancer research.

[19]  Lei Jin,et al.  Downregulation of STOX1 is a novel prognostic biomarker for glioma patients , 2021, Open life sciences.

[20]  Apekshya Panda,et al.  MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations , 2020, Nucleic Acids Res..

[21]  Fusheng Liu,et al.  Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas , 2020, Cell Death & Disease.

[22]  Hao Zhou,et al.  Mitochondrial quality control in cardiac microvascular ischemia-reperfusion injury: New insights into the mechanisms and therapeutic potentials. , 2020, Pharmacological research.

[23]  Xinxin Zhang,et al.  MTH1 Inhibitor TH287 Suppresses Gastric Cancer Development Through the Regulation of PI3K/AKT Signaling. , 2020, Cancer biotherapy & radiopharmaceuticals.

[24]  Joshua A. Bittker,et al.  Discovering the anticancer potential of non-oncology drugs by systematic viability profiling , 2020, Nature Cancer.

[25]  Gopika G. Nair,et al.  Author Correction: Recapitulating endocrine cell clustering in culture promotes maturation of human stem-cell-derived β cells , 2019, Nature Cell Biology.

[26]  M. Pesee,et al.  Survival Analysis of Glioblastoma Multiforme , 2018, Asian Pacific journal of cancer prevention : APJCP.

[27]  G. Song,et al.  Chrysin disrupts intracellular homeostasis through mitochondria-mediated cell death in human choriocarcinoma cells. , 2018, Biochemical and biophysical research communications.

[28]  J. Prudent,et al.  Mitochondrial dynamics: overview of molecular mechanisms , 2018, Essays in biochemistry.

[29]  N. Neamati,et al.  Current Challenges and Opportunities in Treating Glioblastoma , 2018, Pharmacological Reviews.

[30]  A. Ferreira,et al.  The Roles of ROS in Cancer Heterogeneity and Therapy , 2017, Oxidative medicine and cellular longevity.

[31]  Tao Jiang,et al.  Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomas , 2017, Scientific Data.

[32]  Dima Suki,et al.  Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis. , 2016, JAMA oncology.

[33]  Mark D. Johnson,et al.  Birth of MTH1 as a therapeutic target for glioblastoma: MTH1 is indispensable for gliomatumorigenesis. , 2016, American journal of translational research.

[34]  Hsin-Chen Lee,et al.  Role of mitochondrial dysfunction in cancer progression , 2016, Experimental biology and medicine.

[35]  Lin Shi,et al.  Roles of Signaling Pathways in the Epithelial-Mesenchymal Transition in Cancer. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[36]  X. Qu,et al.  Cancer biomarker detection: recent achievements and challenges. , 2015, Chemical Society reviews.

[37]  V. Víctor,et al.  Molecular strategies for targeting antioxidants to mitochondria: therapeutic implications. , 2015, Antioxidants & redox signaling.

[38]  T. Qian,et al.  Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping. , 2015, Neuro-oncology.

[39]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[40]  J. Kirkpatrick,et al.  Recurrent malignant gliomas. , 2014, Seminars in radiation oncology.

[41]  B. Rosen,et al.  Advanced magnetic resonance imaging of the physical processes in human glioblastoma. , 2014, Cancer research.

[42]  M. Ricchetti,et al.  Nitroso-redox balance and mitochondrial homeostasis are regulated by STOX1, a pre-eclampsia-associated gene. , 2014, Antioxidants & redox signaling.

[43]  J. Nunnari,et al.  Mitochondrial form and function , 2014, Nature.

[44]  K. Aldape,et al.  Using the molecular classification of glioblastoma to inform personalized treatment , 2014, The Journal of pathology.

[45]  Hongchuan Jin,et al.  Regulation and function of mitophagy in development and cancer , 2013, Autophagy.

[46]  Mark W. Dewhirst,et al.  ErbB1/2 tyrosine kinase inhibitor mediates oxidative stress-induced apoptosis in inflammatory breast cancer cells , 2012, Breast Cancer Research and Treatment.

[47]  Tsviya Olender,et al.  GeneCards Version 3: the human gene integrator , 2010, Database J. Biol. Databases Curation.

[48]  J. Haorah,et al.  Mechanism of alcohol-induced oxidative stress and neuronal injury. , 2008, Free radical biology & medicine.

[49]  Joshua M. Korn,et al.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.

[50]  K. Tanabe,et al.  Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity , 2006, Immunology.

[51]  Y. Nakabeppu,et al.  MTH1, an oxidized purine nucleoside triphosphatase, prevents the cytotoxicity and neurotoxicity of oxidized purine nucleotides. , 2006, DNA repair.

[52]  R. Gillies,et al.  Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.

[53]  Hoshing Chang,et al.  Involvements of mitochondrial thioredoxin reductase (TrxR2) in cell proliferation. , 2003, Biochemical and biophysical research communications.

[54]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..